Lena Wu, co-founder of Eleni Health, a seed stage company developing an AI-powered, drug-free pain management device addressing chronic pain disorders.

She was previously the CEO, President and co-founder of Intabio, Inc, an analytical instrument company acquired in 2020 by Danaher, and Rogne Biosciences, a therapeutic dermatology company. Lena has 30+ years of industry experience, including board positions in early stage life science companies and senior executive business and corporate development roles at On-Q-ity, cancer diagnostic device company, Caliper Technologies, a microfluidic platform company developing analytical instrumentation systems for life science. Lena has also served as a fractional Chief Business Officer in 35+ early stage companies developing and commercializing life science products, including therapeutics, diagnostics, instruments and reagents. She began her business career at Millennium Pharmaceuticals, following a post-doc in yeast genetics at Harvard and receiving her Ph.D. in molecular pharmacology from Stanford.